MedPath

Evaluation of the effect of krocina in patients with Diminished ovarian reserve

Phase 2
Recruiting
Conditions
Diminished ovarian reserve.
Registration Number
IRCT20220516054872N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
30
Inclusion Criteria

History of uterine bleeding and amenorrhea before 40 years
FSH <10U/L ? AMH<0.5 – 1.1 ng/ml
Infertility without a specific cause

Exclusion Criteria

POI patients with 25 40 IU / ml
POI patients with 25 40 IU / mlPOF patients with a 4-month period of amenorrhea and Chromosomal disease in each pair
Hysterosalpingography, which shows a defective female reproductive system
Genetic disorders such as Turner syndrome
Patients using alkylating agents or radiation therapy
Decreased PTH and aldosterone
Patients with hyper or hypothyroidismType I diabetic patients
Patients with Cushing's disease or Addison's disease
Cases of obesity
History of malignant tumor
Taking antioxidant-related medications in the last 3 months
Use hormone therapy to induce ovulation in the last 2 months
History of taking contraceptives in the last 3 months

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath